tiprankstipranks
Ideaya Biosciences (IDYA)
NASDAQ:IDYA
US Market
IDYA
IDEAYA Biosciences
RESEARCH TOOLSreports

IDEAYA Biosciences (IDYA) Stock News & Sentiment

648 Followers
IDEAYA, AstraZeneca launch global IDE849-Imfinzi lung cancer trial
Premium
Company Announcements
IDEAYA, AstraZeneca launch global IDE849-Imfinzi lung cancer trial
21h ago
8K
IDYA
IDEAYA Biosciences: Operational Trial Delay but High Conviction Buy Ahead of Key Darovasertib Readout
Premium
Ratings
IDEAYA Biosciences: Operational Trial Delay but High Conviction Buy Ahead of Key Darovasertib Readout
19d ago
IDYA
IDEAYA Biosciences: Expanding Precision Oncology Platform and Refocused MTAP Strategy Support Buy Rating
Premium
Ratings
IDEAYA Biosciences: Expanding Precision Oncology Platform and Refocused MTAP Strategy Support Buy Rating
1M ago
IDYA
IDEAYA Biosciences: Methodologically De-Risked OpTimUM-02 Readout and Strong Cash Runway Support Buy Rating
Premium
Ratings
IDEAYA Biosciences: Methodologically De-Risked OpTimUM-02 Readout and Strong Cash Runway Support Buy Rating
2M ago
IDYA
IDEAYA Biosciences: Pipeline Progress and Late-Stage Clinical Expansion Support Reiterated Buy Rating
Premium
Ratings
IDEAYA Biosciences: Pipeline Progress and Late-Stage Clinical Expansion Support Reiterated Buy Rating
2M ago
IDYA
IDEAYA Biosciences: Buy Rating on Darovasertib/Crizotinib Ahead of Pivotal OpतimUM-02 Readout and Supported by Strong Cash Runway
Premium
Ratings
IDEAYA Biosciences: Buy Rating on Darovasertib/Crizotinib Ahead of Pivotal OpतimUM-02 Readout and Supported by Strong Cash Runway
2M ago
IDYA
Multiple Shots on Goal in High-Unmet-Need Oncology: IDEAYA’s Diversified Pipeline and Strong Funding Underpin Buy Rating
Premium
Ratings
Multiple Shots on Goal in High-Unmet-Need Oncology: IDEAYA’s Diversified Pipeline and Strong Funding Underpin Buy Rating
3M ago
IDYA
More IDYA News >

IDYA News on the Web

IDEAYA, AstraZeneca launch global IDE849-Imfinzi lung cancer trial
TipRanks News
Neutral
Unusually active option classes on open April 8th
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH), IDEAYA Biosciences (IDYA) and Bristol-Myers Squibb (BMY)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Pelthos Therapeutics (PTHS), IDEAYA Biosciences (IDYA) and Viridian Therapeutics (VRDN)
TipRanks News
Bullish
Wells Fargo Sticks to Its Buy Rating for IDEAYA Biosciences (IDYA)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Kissei Pharmaceutical Co (OtherKSPHF), PepGen Inc. (PEPG) and IDEAYA Biosciences (IDYA)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG) and IDEAYA Biosciences (IDYA)
TipRanks News
Bullish
Ideaya Biosciences announces first-patient-in for IDE849, IDE161 study
TipRanks News
Bullish

News Score - Last 7 Days

Positive
IDYA
Sector Average
Media Buzz
This Week4 articles
Weekly Average6 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IDYA’s Media Buzz Sentiment?
4 articles about IDYA were published this week. In an average week, 6 articles are published.
    What is IDYA’s weekly average amount of articles?
    In an average week, 6 articles about IDYA are published.
      What is IDYA’s News Sentiment?
      100% of articles about IDYA were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        STAAStaar Surgical
        AORTArtivion
        OWLTOwlet
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week